ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.

Citation data:

Diabetologia, ISSN: 1432-0428, Vol: 60, Issue: 1, Page: 69-80

Publication Year:
2017
Usage 34
Abstract Views 32
Link-outs 2
Captures 12
Readers 11
Exports-Saves 1
Mentions 1
News Mentions 1
Social Media 16
Tweets 16
Citations 4
Citation Indexes 4
PMID:
27766347
DOI:
10.1007/s00125-016-4118-x
ClinicalTrials.gov Identifier:
NCT00182910
Author(s):
Murray, Anne M, Hsu, Fang-Chi, Williamson, Jeff D, Bryan, R Nick, Gerstein, Hertzel C, Sullivan, Mark D, Miller, Michael E, Leng, Iris, Lovato, Laura L, Launer, Lenore J, Action to Control Cardiovascular Risk in Diabetes Follow-On Memory in Diabetes (ACCORDION MIND) Investigators Show More Hide
Publisher(s):
Springer Nature
Tags:
Medicine
Most Recent Tweet View All Tweets
article description
The Memory in Diabetes (MIND) substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study, a double 2x2 factorial parallel-group randomised clinical trial, tested whether intensive compared with standard management of hyperglycaemia, BP or lipid levels reduced cognitive decline and brain atrophy in 2977 people with type 2 diabetes. We describe the results of the observational extension study, ACCORDION MIND (ClinicalTrials.gov registration no. NCT00182910), which aimed to measure the long-term effects of the three ACCORD interventions on cognitive and brain structure outcomes approximately 4 years after the trial ended.

This article has 0 Wikipedia mention.